In this trailer episode, you will be introduced to the newest series for MedEdTalks Primary Care, Obesity Forum FAQs, where experts in the management of patients with overweight and obesity answer questions submitted during the Obesity Forum activities ..read more

In this podcast, expert clinicians discuss topics related to Individualizing Obesity Care and answer audience questions from the Obesity Forum activities ..read more

In this podcast, expert clinicians discuss topics related to Getting Engaged in Obesity Care and answer audience questions from the Obesity Forum activities ..read more

In this podcast, expert clinicians will discuss the phases of COVID-19 infection, including the role of the adaptive immune response in progressive disease ..read more

In this podcast, expert clinicians will discuss evidence-based management of influenza in adult patients at high-risk for complications ..read more

In this podcast, expert clinicians will discuss best practices for the treatment of influenza in pediatric patients ..read more

In this podcast, expert clinicians will discuss multidisciplinary care approaches to consider in tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with a high health care burden, but outcomes can be optimized through coordinated care efforts. Recently, the US Food and Drug Administration approved new treatments for patients with TD. Most providers are unfamiliar with these ..read more

In this podcast, expert clinicians will discuss available therapies for tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with a high health care burden, but outcomes can be optimized through coordinated care efforts. Recently, the US Food and Drug Administration approved new treatments for patients with TD. Most providers are unfamiliar with these novel therapies and the d ..read more

In this podcast, expert clinicians will discuss the symptoms, pathology, and causes of tardive dyskinesia (TD). TD is a neurological disorder characterized by persistent involuntary movements that can be debilitating. It is commonly associated with exposure to dopamine receptor antagonists, including both typical and atypical antipsychotics. TD is associated with a high health care burden, but outcomes can be optimized through coordinated care efforts. Recently, the US Food and Drug Administration approved new treatments for patients with TD. Most providers are unfamiliar with these novel ther ..read more

While the impact of influenza varies, it places a substantial burden on the health of people in the United States  each year. The Centers for Disease Control and Prevention estimates that influenza has resulted in between 9.3 million and 45 million illnesses, between 140,000 and 810,000 hospitalizations, as well as between 12,000 and 61,000 deaths annually since 2010. There is a need for better treatments for patients with influenza infection, preventative measures, and better mitigation for the impact associated with a pandemic. In this podcast, expert clinicians will discuss the la ..read more